Off-label use of prescription medications, a common practice that healthcare providers have long relied on and that pharmaceutical companies have profited from, has become the subject of a great deal of controversy. Billions in settlements have been paid out to patients who were allegedly harmed as a result of the off-label... Read more »

On March 27, 2015, a former Risperdal patient filed a lawsuit in U.S. District Court for the Eastern District of Louisiana against several drug manufacturers, including Janssen Pharmaceuticals and Johnson & Johnson. The complaint is one of several ongoing causes of action against the makers of the powerful antipsychotic drug, which... Read more »

A Risperdal lawsuit that was pending in a Philadelphia court resulted in a mixed outcome for the plaintiff. The 19-year-old man filed the lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, claiming that the defendants’ medication resulted in the abnormal growth of breast tissue. On Friday, March 20, the... Read more »

The drug Risperdal is a powerful antipsychotic medication originally designed and manufactured to treat otherwise-untreatable symptoms of adult schizophrenia. The drug was historically considered an option of last resort, as it carries a risk of several other side effects that could place patients in grave danger of injury or death.... Read more »

A Philadelphia law firm has filed a Risperdal lawsuit against the Department of Health and Human Services and the Food and Drug Administration. The firm represents hundreds of children who have been allegedly injured as a result of ingesting Risperdal. The antipsychotic drug is used to treat a variety of mental/mood... Read more »

The drug known as Risperdal – which is a highly-powerful antipsychotic treatment option manufactured and marketed by Johnson & Johnson and Janssen Pharmaceuticals – has been implicated in yet another lawsuit alleging the unlawful promotion and marketing of the product, as well as an intentional and unlawful failure to disclose... Read more »

The Institute for Safe Medication Practices (ISMP) has relied in recent years on The U.S. Food and Drug Administration’s Adverse Event Reporting System, also known as FAERS, to generate data for its QuarterWatch drug safety reports. FAERS is the federal government’s primary watchdog program for identifying adverse patient events from... Read more »

A resident of Minnesota has filed a Risperdal lawsuit, alleging that the medication resulted in gynecomastia and other severe complications. The lawsuit, which was filed in the U.S. District Court for the District of Minnesota, names Johnson & Johnson Company and Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, as... Read more »

Another Risperdal lawsuit over gynecomastia has been filed, this time in Louisiana. Karon-Jahlil Williams v. Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development, L.L.C. (Case # 5:14-cv-03354) was filed on December 2, 2014 in the US. District Court for the Western District of Louisiana (Shreveport Division). The... Read more »

The powerful prescription medication Risperdal, which is classified as an “atypical antipsychotic,” was recently implicated in a federal personal injury lawsuit filed in United States District Court for the Middle District of Louisiana. At the heart of the plaintiff’s complaint is the assertion that her minor child was wrongfully exposed... Read more »